L-cysteine is the limiting ingredient the body uses to build glutathione, its main internal antioxidant. It is most useful for correcting a shortfall in older or unwell people, where restoring it improved antioxidant status and some strength, thinking, and energy measures. In healthy people the longevity picture is unsettled and even cautionary. (Full Review)
| Marker | Target | Why |
|---|---|---|
| RBC glutathione (GSH) & GSH/GSSG ratio | High-normal GSH; ratio > ~10:1 | Direct readout of the main target of cysteine |
| Plasma total cysteine | Mid-normal, not high | Gauges cysteine status and over-supply |
| Homocysteine | 5–7 µmol/L | Reflects transsulfuration and B-vitamin status upstream of cysteine |
| hs-CRP | < 1.0 mg/L | Tracks inflammation that glutathione repletion may lower |
| Fasting glucose & HbA1c | Glucose 75–90 mg/dL; HbA1c < 5.4% | Monitors metabolic benefit and hypoglycemia risk on glucose-lowering drugs |
| eGFR & urinalysis | eGFR > 90; no cystine crystals | Screens kidney function and stone risk |
| GGT | < 25 U/L (men), < 20 U/L (women) | Rises with oxidative stress and low glutathione |
Cadence: Baseline before starting; ~8–12 weeks after starting to gauge response, then every 6–12 months if use continues, with earlier checks if kidney or glucose concerns exist.